In a major decision, US pharma giant Eli Lilly and Company (India)...

Celltrion signs to buy Eli Lilly’s U.S. plant for USD 330 million

South Korea's Celltrion Inc. has signed an agreement to acquire Eli Lilly and Company's U.S. biopharmaceutical...

Lilly Partners with API to launch ‘Obesity Gurukul’

Eli Lilly and Company (India), in collaboration with the Association of Physicians of India (API), on Friday...

Tirzepatide tops semaglutide in trial

Eli Lilly and Company announced on Monday detailed results from SURMOUNT-5, a phase 3b open-label clinical trial,...

Lilly's orforglipron consistent with injectable GLP-1 medicines

According to an official statement from Eli Lilly and Company, "Orforglipron is the first oral small-molecule...

Eli Lilly's antibody cocktail drug gets emergency use nod in India

New Delhi [India], June 1 (ANI): Eli Lilly and Company India on Tuesday announced that it has received emergency use...

Lilly India gets nod for use of monoclonal antibody drugs for...

New Delhi [India], June 1 (ANI): Eli Lilly and Company India said on Tuesday it has received permission for...

Lilly signs pact with Natco to accelerate availability of...

New Delhi [India], May 17 (ANI): Eli Lilly and Company said on Monday it has issued an additional royalty-free,...

Lilly signs 3 more pacts to accelerate availability of...

New Delhi [India], May 13 (ANI): Eli Lilly and Company said on Thursday it has issued additional royalty-free,...

Dr Reddy's enters into licensing agreement with Eli Lilly for...

Hyderabad (Telangana) [India], May 12 (ANI): Dr Reddy's Laboratories on Tuesday said that it has entered into a...